Saturday, 28 May, 2022
Advertisement
HomeHealthPfizer-BioNTech vaccine neutralises Brazilian Covid strain in lab experiments

Pfizer-BioNTech vaccine neutralises Brazilian Covid strain in lab experiments

While the research, performed by University of Texas Medical Branch in Galveston, needs to be validated with real-world data, it offers another reason for optimism.

Text Size:

Munich: The Covid-19 vaccine from Pfizer Inc. and BioNTech SE showed a high ability to neutralize coronavirus strains first detected in Brazil, the U.K. and South Africa, according to a new study.

In lab experiments, the shot demonstrated “roughly equivalent” levels of neutralizing activity against the Brazil and U.K. strains compared with a version of the virus from early last year. It also showed “robust but lower” activity against the South Africa variant, according to a letter to the New England Journal of Medicine.

While the research needs to be validated with real-world data, it offers another reason for optimism that the Covid vaccines are generally performing well against variants of the virus.

The research was supported by Pfizer and BioNTech and performed by scientists at the University of Texas Medical Branch in Galveston, Texas.

The study tested serum samples taken from people either two or four weeks after they had received their second dose of the Pfizer-BioNTech shot. That was pitted against viruses that had been engineered to have mutations from the three virus lineages.

While vaccine developers including BioNTech are already working on new versions of their shots to combat mutant strains, the current generation of Covid shots are already showing some encouraging results against the variants.

The vaccine from AstraZeneca Plc provides protection against the Brazil variant, Reuters reported, citing the country’s Fiocruz biomedical institute.

The strain first found in South Africa, however, has at times been tougher to target. The country switched to using Johnson & Johnson shots last month for its initial inoculations after a small study showed the AstraZeneca shots had little impact on mild infections caused by the variant. –Bloomberg


Also read: Single dose of Pfizer, AstraZeneca vaccines effective, work against UK variant too — Study


 

Subscribe to our channels on YouTube & Telegram

Why news media is in crisis & How you can fix it

India needs free, fair, non-hyphenated and questioning journalism even more as it faces multiple crises.

But the news media is in a crisis of its own. There have been brutal layoffs and pay-cuts. The best of journalism is shrinking, yielding to crude prime-time spectacle.

ThePrint has the finest young reporters, columnists and editors working for it. Sustaining journalism of this quality needs smart and thinking people like you to pay for it. Whether you live in India or overseas, you can do it here.

Support Our Journalism

Most Popular

×